New proteomic clock predicts biological age and major health risks across diverse populations

Study developed a proteomic age clock using plasma proteins to accurately predict biological age and associated health risks, offering a robust tool for forecasting age-related diseases and mortality.

Gilead and Genesis partner to create novel therapies using AI

Gilead holds sole rights for clinical development and potential commercialisation of the compounds developed under the deal. Credit: JHVEPhoto/Shutterstock. Gilead Sciences has announced a strategic

September 11, 2024

Biotest AG opens 13th plasma collection center in Germany – Biotech Investments

EQS-News: Biotest AG / Key word(s): Miscellaneous Biotest AG opens 13th plasma collection center in Germany 05.09.2024 / 09:00 CET/CEST The issuer is solely responsible

September 6, 2024

Blueprint to pull Gavreto in certain markets, shelve EGFR programs as it focuses on Ayvakit launch

As Blueprint Medicines braces itself for a future without a major Roche collaboration, the Massachusetts biotech is pulling its RET inhibitor from certain markets and

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.